Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

CBDL's Recent Additions to Active Sales Channels Fuel 18-Month Sales Projections; CBD Vault(TM) Products' Projected 2025 Sales Revenues to Reach $1.8 Million
Healthcare & PharmaceuticalCompany Update

CBDL's Recent Additions to Active Sales Channels Fuel 18-Month Sales Projections; CBD Vault(TM) Products' Projected 2025 Sales Revenues to Reach $1.8 Million

July 24, 2024 8:00 AM

SCOTTSDALE, AZ / ACCESSWIRE / July 24, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly-owned subsidiary, The CBD Vault Inc., a leading innovator in the CBD industry, has announced that it increased its revenue projection for 2025 to $1.8 million on the strength of its recently launched CBD VaultTM brand sales. The forecast increase is based both on anticipated organic growth and expected revenue contribution from recently...

Read more
NBA Athlete Ben Sheppard From the Indiana Pacers Launches Exciting Business Partnership With Earth’s Splendor Vitamin and Supplement Brand
Healthcare & PharmaceuticalPartnerships

NBA Athlete Ben Sheppard From the Indiana Pacers Launches Exciting Business Partnership With Earth’s Splendor Vitamin and Supplement Brand

July 24, 2024 8:00 AM

This new partnership reflects Ben's commitment to his physical and mental fitness, prioritizing peak performance and overall wellness as he prepares for the demanding 2024-2025 NBA season.HAUPPAUGE, NY / ACCESSWIRE / July 24, 2024 / Earth's Splendor is thrilled to announce the launch of the "Treat Your Body Like a Professional" campaign in partnership with Ben Sheppard, one of the NBA's most promising young talents. Embracing the importance of...

Read more
Beyond
Healthcare & PharmaceuticalCompany Update

Beyond "One Bug, One Drug" - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral

July 24, 2024 7:45 AM

CHATHAM, NJ / ACCESSWIRE / July 24, 2024 / From anthrax to the plague, biological warfare is a real threat to U.S. forces and civilians, so much so the Pentagon budgeted about $2 billion for the country's biological defense for the coming fiscal year. It's also why the U.S. Department of Defense is seeking broad-spectrum antiviral drugs and teaming up with the biotech companies developing them. That's the case with Tonix Pharmaceuticals...

Read more
Custom Health Celebrates the Launch of the Opioid Addiction Deterrence Task Force (OADTF) by the American Medical Technology Coalition
Healthcare & PharmaceuticalCompany Update

Custom Health Celebrates the Launch of the Opioid Addiction Deterrence Task Force (OADTF) by the American Medical Technology Coalition

July 24, 2024 7:35 AM

KELOWNA, BC and WASHINGTON, DC / ACCESSWIRE / July 24, 2024 / Custom Health Inc. ("Custom Health" or the "Company") is celebrating the launch of the Opioid Addiction Deterrence Task Force (the "OADTF" or the "Task Force") by the American Medical Technology Coalition (the "AMTC" or the "Coalition"), an alliance of organizations dedicated to advancing medical technology and transforming healthcare delivery, of which Custom Health is a member. This...

Read more
COVID is Here to Stay and NV-387 is a Much Needed Drug Against It, Reminds NanoViricides
Healthcare & PharmaceuticalCompany Update

COVID is Here to Stay and NV-387 is a Much Needed Drug Against It, Reminds NanoViricides

July 24, 2024 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today reminds the strong safety and effectiveness against coronaviruses demonstrated by its lead clinical drug candidate NV-387."President Joe Biden has thankfully recovered from the bout of COVID caused by a new variant," said Anil R. Diwan, PhD, President and Executive Chairman of the Company, adding, "This again...

Read more
Ampersand Biosciences and Bioz Partner to Provide Third-Party Product Usage to Researchers
Healthcare & PharmaceuticalPartnerships

Ampersand Biosciences and Bioz Partner to Provide Third-Party Product Usage to Researchers

July 24, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / July 24, 2024 / Bioz, Inc., the world's leading life science-focused AI company, and Ampersand Biosciences, a New York-based immunoassay development company, have announced that Bioz's patented citation display widgets are now live on the Ampersand Biosciences website. This collaboration enables visitors to view and interact with actual third-party usage of Ampersand products from peer-reviewed scientific journals,...

Read more
Transforming Lives Through Affordable and Structured Sober Living
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Transforming Lives Through Affordable and Structured Sober Living

July 24, 2024 3:00 AM

In a world where the battle against substance abuse claims countless lives each year, one man's vision for affordable, ethical and structured sober living is making a monumental impact. Tom Fay, the founder of Gambit Recovery, has turned his dream into reality, creating a sanctuary for those seeking a fresh start. With a mission to provide supportive housing for individuals recovering from addiction, Gambit Recovery has become a respected and...

Read more
GLG Life Tech Corporation Reports 2024 First Quarter Financial Results
Healthcare & PharmaceuticalEarnings

GLG Life Tech Corporation Reports 2024 First Quarter Financial Results

July 23, 2024 8:15 PM

VANCOUVER, BC / ACCESSWIRE / July 23, 2024 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three months ended March 31, 2024. The complete set of financial statements and management discussion and analysis are available on SEDAR and on the Company's website at...

Read more
​​​​​​​Fortified Health Security Publishes 2024 Mid-Year Healthcare Cybersecurity Report
Healthcare & PharmaceuticalCompany Update

​​​​​​​Fortified Health Security Publishes 2024 Mid-Year Healthcare Cybersecurity Report

July 23, 2024 11:00 AM

Fortified Health Security (Fortified), a Best in KLAS managed security services provider (MSSP) specializing in healthcare cybersecurity, today released the 2024 Mid-Year Horizon Report, a semiannual publication on cybersecurity news, trends, and guidance for healthcare organizations.The report highlights an alarming reality in the wake of major data breaches to Change Healthcare and Ascension, which have yet to be reported to the Office for...

Read more
CGFNS International Joins WHO Stakeholder Network to Advance Rehabilitation Care
Healthcare & PharmaceuticalCompany Update

CGFNS International Joins WHO Stakeholder Network to Advance Rehabilitation Care

July 23, 2024 10:00 AM

PHILADELPHIA, PA / ACCESSWIRE / July 23, 2024 / CGFNS International, a worldwide leader in international credentials evaluation and certification to support health worker careers, has been inducted into the World Rehabilitation Alliance (WRA).CGFNS International The WRA is the World Health Organization's global network of stakeholders whose mission is to advocate for the implementation of WHO's Rehabilitation 2030 initiative, which aims to...

Read more
Simulab Corporation Unveils Cutting-Edge Ultrasound-Guided Intravenous Access Arm Trainer
Healthcare & PharmaceuticalProduct Announcements

Simulab Corporation Unveils Cutting-Edge Ultrasound-Guided Intravenous Access Arm Trainer

July 23, 2024 10:00 AM

New Technology in Intravenous Access Training Compatible With Ultrasound Imaging for Realistic EducationSEATTLE, WA / ACCESSWIRE / July 23, 2024 / Simulab Corporation, a leading healthcare simulation manufacturing company headquartered in Seattle, Washington, is pleased to announce the launch of its latest innovation - the Ultrasound-Guided Intravenous Access Arm. With a legacy of providing top-tier medical and healthcare simulation solutions...

Read more
North America Injectable Drug Industry Set to Total USD 407.2 Billion by 2034, Spurred by Rising Chronic Disease Incidence and Surging Generic Injectable Approvals
Healthcare & PharmaceuticalCompany Update

North America Injectable Drug Industry Set to Total USD 407.2 Billion by 2034, Spurred by Rising Chronic Disease Incidence and Surging Generic Injectable Approvals

July 23, 2024 9:30 AM

As per Future Market Insights' latest analysis, the North America Injectable Drug Market value is set to total USD 209.2 billion in 2024. Sales in the region are forecast to soar at a healthy CAGR of 6.9%, resulting in a staggering valuation of USD 407.2 billion by 2034.Several factors are expected to boost growth of the injectable drug industry in North America through 2034. These include growing prevalence of chronic diseases like cancer &...

Read more
IntoValue, Inc Welcomes Dr. Strongwater to Board of Directors
Healthcare & PharmaceuticalCompany Update

IntoValue, Inc Welcomes Dr. Strongwater to Board of Directors

July 23, 2024 9:00 AM

Technology enabled company accelerates health systems success in direct to employer arrangementsWASHINGTON, DC / ACCESSWIRE / July 23, 2024 / IntoValue, Inc, a pioneering healthcare direct-to-employer enablement company, proudly announces the appointment of Dr. Steven Strongwater to its Board of Directors. Dr. Strongwater brings a wealth of expertise to IntoValue, renowned nationally as a leader in population health and quality. His accolades...

Read more
SimplyHome Awarded Grant to Enhance Access to Enabling Technology for HCBS Services in Arkansas
Healthcare & PharmaceuticalAwards

SimplyHome Awarded Grant to Enhance Access to Enabling Technology for HCBS Services in Arkansas

July 23, 2024 9:00 AM

SimplyHome is proud to announce its recent award of the "Planning for the Future: Enabling Technology Grant" from the Arkansas Department of Human Services (DHS).ASHEVILLE, NC / ACCESSWIRE / July 23, 2024 / SimplyHome is proud to announce its recent award of the "Planning for the Future: Enabling Technology Grant" from the Arkansas Department of Human Services (DHS). This initiative aims to enhance access to Home and Community-Based Services...

Read more
Transparency Launches To Forge The Future Of Drug Safety With Portable Test Kits For Every Substance
Healthcare & PharmaceuticalCompany Update

Transparency Launches To Forge The Future Of Drug Safety With Portable Test Kits For Every Substance

July 23, 2024 9:00 AM

Transparency, a harm reduction organization providing at-home drug testing kits for any substance, today announced its official launch and formation as the parent organization of the Bunk Police. Celebrated for its strong impact in the harm reduction space, the Bunk Police provides critical education and drug testing services to enhance safety and awareness among music festival and concert attendees. Transparency builds on this strong foundation...

Read more
Mann Eye Institute Introduces Cutting-Edge miCOR Technology for Advanced Cataract Surgery
Healthcare & PharmaceuticalProduct Announcements

Mann Eye Institute Introduces Cutting-Edge miCOR Technology for Advanced Cataract Surgery

July 23, 2024 9:00 AM

HOUSTON, TX / ACCESSWIRE / July 23, 2024 / Mann Eye Institute, a leader in ophthalmologic care, proudly announces the integration of the ZEISS miCOR 700 technology into their cataract surgery procedures. This innovative lens extraction device represents the future of cataract treatment, offering enhanced precision, safety, and efficiency. The ZEISS miCOR 700 revolutionizes lens extraction by eliminating the need for ultrasound. Unlike...

Read more
TIXiMED Receives IND Approval from the FDA for its Novel Oral Antidiabetic, TIX100
Healthcare & PharmaceuticalCompany Update

TIXiMED Receives IND Approval from the FDA for its Novel Oral Antidiabetic, TIX100

July 23, 2024 9:00 AM

TIXiMED, Inc. (https://tiximed.com), a clinical stage pharmaceutical company based on the breakthrough discovery that TXNIP plays an important role in the development and progression of diabetes, obtained Investigational New Drug (IND) approval from the United States Food and Drug Administration (FDA) for its oral type 1 diabetes drug, the specific TXNIP inhibitor, TIX100. This is a major milestone in the development of the company's novel...

Read more
Dr. Paul Nassif Honored in Newsweek's 2024 Ranking of America's Best Plastic Surgeons
Healthcare & PharmaceuticalCompany Update

Dr. Paul Nassif Honored in Newsweek's 2024 Ranking of America's Best Plastic Surgeons

July 23, 2024 8:45 AM

BEVERLY HILLS, CA / ACCESSWIRE / July 23, 2024 / Facial plastic and reconstructive surgeon, Dr. Paul Nassif, has been recognized in Newsweek's prestigious list of America's Best Plastic Surgeons 2024 for the second time. Dr. Nassif is known for his expertise and precision in facelift, rhinoplasty and eyelid surgery and has achieved a distinguished position among the top plastic surgeons in the country. Dr. Paul Nassif Newsweek, in collaboration...

Read more
Ainos Enrolls First Subject for Clinical Study of VELDONA-Based Animal FCGS Drug
Healthcare & PharmaceuticalCompany Update

Ainos Enrolls First Subject for Clinical Study of VELDONA-Based Animal FCGS Drug

July 23, 2024 8:30 AM

SAN DIEGO, CA / ACCESSWIRE / July 23, 2024 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and low-dose interferon therapeutics ("VELDONA"), today announced it has enrolled the first subject for its Taiwanese clinical study of VELDONA®-based animal drug in treating feline chronic gingivostomatitis ("FCGS"), a serious and painful chronic...

Read more
Jaguar Health Reports Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer
Healthcare & PharmaceuticalCompany Update

Jaguar Health Reports Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer

July 23, 2024 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / July 23, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced the results from its initial analysis of the pivotal Phase 3 OnTarget trial of crofelemer for prophylaxis of diarrhea in adult cancer patients with solid tumors receiving targeted therapy with or without standard chemotherapy. Crofelemer is an FDA-approved prescription drug for the symptomatic relief of diarrhea in adult HIV/AIDS...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?